Literature DB >> 2610264

Analysis and comparison of sigmoidal curves: application to dose-response data.

J B Meddings1, R B Scott, G H Fick.   

Abstract

A number of physiological or pharmacological studies generate sigmoidal dose-response curves. Ideally, data analysis should provide numerical solutions for curve parameters. In addition, for curves obtained under different experimental conditions, testing for significant differences should be easily performed. We have reviewed the literature over the past 3 years in six journals publishing papers in the field of gastrointestinal physiology and established the curve analysis technique used in each. Using simulated experimental data of known error structure, we have compared these techniques with nonlinear regression analysis. In terms of their ability to provide accurate estimates of ED50 and maximal response, none approached the accuracy and precision of nonlinear regression. This technique is as easily performed as the classic methods and additionally provides an opportunity for rigorous statistical analysis of data. We present a method of determining the significance of differences found in the ED50 and maximal response under different experimental conditions. The method is versatile and applicable to a variety of different physiological and pharmacological dose-response curves.

Mesh:

Substances:

Year:  1989        PMID: 2610264     DOI: 10.1152/ajpgi.1989.257.6.G982

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  Effect of a dietary nonionic surfactant on small intestinal nutrient transport.

Authors:  L Donegan; S A Hudye; M E Olson; J A Hardin; D G Gall
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

2.  Intestinal absorption of magnesium from food and supplements.

Authors:  K D Fine; C A Santa Ana; J L Porter; J S Fordtran
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

3.  Nonlinear model-based estimates of IC(50) for studies involving continuous therapeutic dose-response data.

Authors:  Robert H Lyles; Cliff Poindexter; Angelo Evans; Milton Brown; Carlton R Cooper
Journal:  Contemp Clin Trials       Date:  2008-06-06       Impact factor: 2.226

4.  Adenomatous human parathyroid cells exhibit impaired sensitivity to L-amino acids.

Authors:  H-C Mun; S C Brennan; L Delbridge; M Wilkinson; E M Brown; A D Conigrave
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

5.  The effect of epidermal growth factor on brush border surface area and function in the distal remnant following resection in the rabbit.

Authors:  J A Hardin; B Chung; E V O'loughlin; D G Gall
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

6.  Effect of a novel inhibitor of cyclic AMP phosphodiesterase, E-1020, on cytosolic Ca++ level and contraction in vascular smooth muscle.

Authors:  M Tajimi; H Ozaki; K Sato; H Karaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

7.  Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity.

Authors:  William J Perkins; David O Warner; Keith A Jones
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

8.  Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.

Authors:  D M Lanese; J D Conger
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Hibernation enhances D-glucose uptake by intestinal brush border membrane vesicles in ground squirrels.

Authors:  H V Carey; N S Sills
Journal:  J Comp Physiol B       Date:  1996       Impact factor: 2.200

10.  Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation.

Authors:  William J Perkins; Susan Kost; Mark Danielson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-30       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.